Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Drugs Process-for-preparation-of-a-microbial-agent

 Feeding tray for multiwell test apparatus
This invention will be described herein with reference to the growing and use of cells on a ...


 Neo-tryptophan
What is claimed is: 1. A method of making a neurotensin polypeptide containing neo-tryptophan, said ...


 Human immunodeficiency virus decoy
OF THE INVENTION The present invention has wide application to immunologic procedures and methods ...


 Capsid forming and cystein modified chimaeric MS2-coat protein
We claim: 1. A modified coat protein capable of forming a capsid which comprises the coat protein ...


 Polynucleotides related to monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
This invention relates to the discovery of an anti-idiotype antibody that is capable of recruiting ...


 Strategically modified hepatitis B core proteins and their derivatives
The present invention relates to a strategically modified hepatitis B core (HBc) protein that is ...


 Chimeric biotin-binding papillomavirus protein
OF THE INVENTION The first domain of the chimeric protein includes at least a portion of a ...


 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
OF THE INVENTION DEFINITIONS As used in this application, the following words or phrases have the ...


 MYPPPY variants of CTL A4 and uses thereof
OF THE INVENTION Definition As used in this application, the following words or phrases have the ...


 CTLA4 receptor and uses thereof
OF THE INVENTION DEFINITION As used in this application, the following words or phrases have the ...


 Process for preparation of a microbial agent

Details
Inventors: Das, Bina Pina;
Assignee: National Institute of Communicable Diseases (Delhi, IN)
Primary Examiner: Graser; Jennifer E.
Assistant Examiner:
Attorney, Agent or Firm: Venable LLP Voorhees; Catherine M. Lepping; Kavita B.

A method of killing mosquito larvae and particularly the species comprising Culex tritaeniorhynchus, Cx. pseudovishnui, Cx. (Cx) sp., Cx. (Lutzia) sp. and Anopheles hyrcanus group which comprises in allowing Chilodonella uncinata as a ciliated protozoa to be present in said host larvae, allowing the ciliated protozoa to form a hole in the wall of the larvae and to enter into the haemocoelomic cavity of the larvae and to thereby allow the ciliate to feed on the host larvae and simultaneously allowing the host larvae to grow and allow a multiplication of the ciliate, and whereby the multiplied ciliates kill the host larvae.

DETAILED DESCRIPTION I claim: 1.
A microbial control agent made by the process of: isolating Chilodonella uncinata; colonizing Chilodonella uncinata under laboratory conditions using artificial media; submerging said Chiodonella uncinata in sterile sand; allowing the Chilodonella uncinata and sterile sand to dry at room temperature; thereby producing a dry formulation of Chilodonella uncinata.
2.
The microbial agent of claim 1, wherein said Chilodonella uncinata are isolated from infected larvae and adult mosquitoes.
3.
The microbial agent of claim 1, wherein said dry formulation comprises inactive Chilodonella uncinata.
4.
A method of killing mosquitoes comprising administering the microbial agent of claim 1.
5.
The method of claim 4, wherein said microbial control agent is released in distilled water containing mosquito larvae under conditions such that inactive Chilodonella uncinata is reconstituted, reconstituted Chilodonella uncinata attacks and enters the larvae, and the Chilodonella uncinata kills the larvae and escapes the larvae.
6.
The method of claim 4, wherein said reconstituted Chilodonella uncinata enter the larvae through a cuticle by forming small holes in the cuticle.
7.
The method of claim 5, wherein the reconstituted Chilodonella uncinata enter the larvae through a haemocoelomic cavity of the larvae.
8.
The method of claim 5, wherein said Chilodonella uncinata which escapes from the dead larvae is cultivated at room temperature in the presence of artificial nutrition media to produce daughter cells, thereby continuing a cycle of infection.
9.
The method of claim 5, wherein said reconstituted Chilodonella uncinata remains active for at least two successive generations under lab laboratory conditions and is capable of being dispersed in the environment.
10.
A microbial control agent comprising isolated Chilodonella uncinata in a dry formulation of sterile sand which when released in water works as an effective biological agent for mosquito vectors of human disease



Related patents
  Product of infectious respiratory syncytial virus from cloned nucleotide sequences
The present invention provides an isolated infectious RSV particle which comprises a recombinant RSV genome or antigenome, a nucleocapsid (N) protein, a nucleocapsid ...
  Protein tyrosine kinase substrate LAT and its use in the indentification of (ant)agonists of the kinase
OF SPECIFIC EMBODIMENTS Generally, the nomenclature used hereafter and the laboratory procedures in cell culture, molecular genetics, and nucleic acid chemistry and ...
  Biodegradable and biocompatible polymeric microspheres encapsulating Salmonella enteritidis bacteria
In accordance with the present invention, there are provided long term release, biocompatible and biodegradable, porous, polymeric microcapsules comprising whole killed S...
  Method for producing yeast expressed HPV types 6 and 16 capsid proteins
What is claimed is: 1. A virus-like particle (VLP) comprising a first late 1 (L1) capsid protein from human papilloma virus (HPV) type 6 and a second L1 capsid protein ...
  Exchangeable template reaction
OF THE INVENTION Description of the Exchangeable Template Reaction (ETR) mechanism. The ETR is a method for the synthesis of long polynucleotide DNA fragments using ...
  Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
As has been discussed supra, it is desirable to produce human immunoglobulins that are reactive with specific human antigens that are promising therapeutic and/or ...
  Transgenic non-human animals capable of producing heterologous antibodies
The design of a transgenic non-human animal that responds to foreign antigen stimulation with a heterologous antibody repertoire, requires that the heterologous ...
  Transgenic non-human animals capable of producing heterologous antibodies
As has been discussed supra, it is desirable to produce human immunoglobulins that are reactive with specific human antigens that are promising therapeutic and/or ...
  Transgenic non-human animals for producing heterologous antibodies
As has been discussed supra, it is desirable to produce human immunoglobulins that are reactive with specific human antigens that are promising therapeutic and/or ...
  Nucleic acids encoding lymphoid CD30 antigen
We claim: 1. An isolated nucleic acid molecule comprising a polynucleotide having a sequence encoding the amino acid sequence of SEQ. ID. NO.: 2. 2. A recombinant vector ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved